First American Bank’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-32,645
Closed -$2.05M 207
2026
Q1
$2.05M Sell
32,645
-3,715
-10% -$259K 0.13% 106
2025
Q4
$2.41M Buy
36,360
+3,461
+11% +$224K 0.15% 94
2025
Q3
$2.21M Buy
32,899
+5,637
+21% +$446K 0.14% 92
2025
Q2
$2.38M Buy
27,262
+274
+1% +$21.5K 0.16% 89
2025
Q1
$1.84M Buy
26,988
+725
+3% +$59.2K 0.14% 103
2024
Q4
$2.04M Buy
+26,263
New +$1.94M 0.14% 96

Other funds holding DXCM

First American Bank's DXCM Position: Q2 2026 in Review

First American Bank sold out of DexCom (DXCM) in Q2 2026, closing a stake of 32,645 shares — an estimated $2.05M sold.

First American Bank first reported a position in DXCM in Q4 2024 and held it in 6 quarters. The position peaked at $2.41M in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • First American Bank reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • First American Bank sold 32,645 DexCom shares in Q2 2026, an estimated $2.05M.
  • First American Bank first reported a position in DexCom in Q4 2024 and held it in 6 quarters.
  • First American Bank's DexCom position peaked at $2.41M in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.